Clinical trial
Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression
NCT00031317 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression
- Lead sponsor
- National Institute of Mental Health (NIMH)
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- June 30, 2005
- Enrollment
- 60
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.